Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

Discover a study that aims to customise CIC profiles for patients, providing insights into which stages of the cycle are most ...

Biohacking is not now limited to tech-savvy rebels, it is an experiment on human evolution itself. Whether we are ready to face the music or not, biohacking is already at our doorstep. While ...

We recently compiled a list of the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we are going to ...

ARK Investment Management LLC, more commonly known as ARK Invest, is an American investment management firm headquartered in ...

A virologist named Beata Halassy recently made headlines after publishing a report of successfully treating her own breast ...

Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...